U.S. District Court Strikes Down 2023 CMS Final Rule on Pharmaceutical Manufacturer Coupons and Best Price
The New Sales Model: Virtual Engagement in the Time of COVID-19 August 10th, 2020 U.S. District Court Strikes Down 2023 CMS Final Rule on Pharmaceutical Manufacturer Coupons and Best Price On Tuesday, May 17, 2022, the U.S. District Court for the District of Columbia issued a Memorandum Opinion granting a motion for summary judgment for the Pharmaceutical Research and Manufacturers of America (PhRMA) in its case challenging the CMS Final Rule on manufacturer copay offers and Best Price. As a result, the rule – previously scheduled to go into effect [...]